Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration

Research output: Contribution to journalArticlepeer-review

145 Scopus citations

Fingerprint

Dive into the research topics of 'Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration'. Together they form a unique fingerprint.

Medicine & Life Sciences